Healthcare and Life Science
Co-development agreement with US insulin pump device company for AT278 and sale of royalty and technology access fees for up to $11 million
This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR"). Arecor Therapeutics plc(“Arecor” or the “Company”)Co-development Agreement with US Insulin Pump Device Company for AT...
Invent: Life Sciences podcast - make way for advanced therapies – why manufacturing could be coming to a hospital near you
Season 3, Episode 6. In our last episode, we explored the manufacturing strategies that will be key to scaling advanced therapies. Now, we turn our focus to the UK, where new regulatory frameworks and regional collaboration are changing how therapies reach patients. ...
How to solve in-building connectivity issues
Solve in-building wireless challenges without the long timelines.Wilson Connectivity’s Hybrid DAS combines proven amplifier technology with fibre-optic reach, enabling rapid deployment for buildings from 100k to 500k sq ft.The results:Up to 80% faster installation vs. traditional DAS80%...
New IDTechEx Report: Biomanufacturing Specialty Chemicals 2026-2036
IDTechEx's new report "Biomanufacturing Specialty Chemicals 2026-2036" examines the role of white biotechnology in producing specialty chemicals, focusing on food additives, cosmetic and personal care ingredients, pigments, and enzymes. ...
Quantum computing and AI: Synergy or deep tech rivalry?
In this article, IDTechEx explores the fascinating relationship between quantum computing and AI: two supposed tech revolutions that frequently grab the spotlight. Underneath the hype, there exist both technical synergies and competing market forces. ...
Daiichi Sankyo joins Milner Therapeutics Consortium
Daiichi Sankyo has joined the Milner Therapeutics Consortium as our tenth pharma partner. ...
SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies
First commercially available NK (natural killer) cell-specific promoter library enables precise and controllable gene expressionPortfolio of synthetic promoters validates SynGenSys’ platform for engineering targeted, tissue-specific gene regulation control elementsSheffield, UK, 23 Sept...
Atelerix signs agreement with CliniSciences to broaden access to cryo-free preservation solutions across Europe and North Africa
Agreement with specialist life science and diagnostic labs distributor expands global operational reach and market penetrationNew distribution channels to improve access to Atelerix’s non-cryogenic cell preservation solutions and strengthen local technical supportNewcastle, UK, 23 Septe...
A leading hospital charity thanks its Daily Mirror Pride of Britain Regional Fundraiser of the Year nominee – saying they "couldn’t be prouder”
This year's Daily Mirror Pride of Britain Awards will be televised live on ITV next month. Prior to all the finalists getting through, they go through a process where regional news teams select a fundraiser from the 17 regions across the UK. For the second year running, a fundraiser f...
Reimagining COPD care for 450 million people: A global mission at scale
A global epidemicCOPD is a silent killer. It is the third leading cause of death worldwide, taking three million lives annually. More than 450 million are diagnosed, and the actual number may reach 900 million when undiagnosed cases are counted. In the EU, COPD costs €38.6 billion annua...